USNA Stock Overview
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
USANA Health Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$44.75 |
| 52 Week High | US$69.60 |
| 52 Week Low | US$42.59 |
| Beta | 0.91 |
| 1 Month Change | -6.77% |
| 3 Month Change | -8.34% |
| 1 Year Change | -34.09% |
| 3 Year Change | -49.61% |
| 5 Year Change | -51.01% |
| Change since IPO | 7,243.59% |
Recent News & Updates
Recent updates
USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares
Apr 04
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Feb 08Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?
Jan 06USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation
Oct 23Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?
Sep 09Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Jul 27USANA Earnings Preview: From China's Challenge To India's Promise
Jul 21USANA Health Sciences says Brown will transition to CEO in July 2023
Feb 13Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture
Feb 02USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates
Oct 25Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return
Oct 18Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?
Jul 22Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled
Jul 07Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?
Jun 14Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?
May 31USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside
Apr 28Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future
Mar 05USANA: 15x P/E, 14% Net Cash, Stock Repurchases
Feb 17A Look At The Intrinsic Value Of USANA Health Sciences, Inc. (NYSE:USNA)
Jan 24At US$99.77, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?
Jan 11Here's Why I Think USANA Health Sciences (NYSE:USNA) Might Deserve Your Attention Today
Nov 15USANA: Q3 Mixed Results, We See 35% Upside, 15% 10-Year EPS CAGR
Oct 28Shareholder Returns
| USNA | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 4.0% | 5.4% | 1.2% |
| 1Y | -34.1% | -25.4% | 24.7% |
Return vs Industry: USNA underperformed the US Personal Products industry which returned -25.4% over the past year.
Return vs Market: USNA underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| USNA volatility | |
|---|---|
| USNA Average Weekly Movement | 4.3% |
| Personal Products Industry Average Movement | 8.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: USNA has not had significant price volatility in the past 3 months.
Volatility Over Time: USNA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,800 | Jim Brown | www.usana.com |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups.
USANA Health Sciences, Inc. Fundamentals Summary
| USNA fundamental statistics | |
|---|---|
| Market cap | US$861.01m |
| Earnings (TTM) | US$63.79m |
| Revenue (TTM) | US$921.01m |
13.5x
P/E Ratio0.9x
P/S RatioIs USNA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| USNA income statement (TTM) | |
|---|---|
| Revenue | US$921.01m |
| Cost of Revenue | US$176.69m |
| Gross Profit | US$744.32m |
| Other Expenses | US$680.53m |
| Earnings | US$63.79m |
Last Reported Earnings
Dec 30, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 3.32 |
| Gross Margin | 80.82% |
| Net Profit Margin | 6.93% |
| Debt/Equity Ratio | 0.2% |
How did USNA perform over the long term?
See historical performance and comparison